54915-41-2

Usage

Uses

Used in Pharmaceutical Synthesis:
(2-Methyl-6-nitrophenyl)Methanol is used as an intermediate in the pharmaceutical industry for the synthesis of various drugs. Its unique chemical structure allows it to be a key component in the creation of new medicinal compounds.
Used in Agrochemical Production:
In the agrochemical sector, (2-Methyl-6-nitrophenyl)Methanol serves as an intermediate in the production of pesticides and other agricultural chemicals, contributing to the development of effective solutions for crop protection.
Used in Dye Manufacturing:
(2-Methyl-6-nitrophenyl)Methanol is also utilized in the dye industry, where it acts as an intermediate for the synthesis of different types of dyes, adding to the range of colorants available for various applications.
Used in Organic Synthesis Research:
(2-Methyl-6-nitrophenyl)Methanol is used as a reagent in organic synthesis, particularly for the preparation of various derivatives and analogs, which are essential for advancing chemical research and development.
Used in Antimicrobial Applications:
Due to its reported antimicrobial properties, (2-Methyl-6-nitrophenyl)Methanol has potential uses in the development of antimicrobial agents, which could be applied in various industries to combat microbial infections.
Used in Anticancer Research:
With its potential anticancer properties, (2-Methyl-6-nitrophenyl)Methanol is a valuable compound for pharmaceutical development, particularly in the research and creation of new cancer treatments.

Upstream product

• 66232-57-3 2-methyl-6-nitrobenzoyl chloride 
• 3113-72-2 5-methyl-2-nitrobenzoic acid 
• 13506-76-8 2-methyl-6-nitrobenzoic acid 
• 61940-22-5 methyl 2-methyl-6-nitrobenzoate 

Downstream Products

• 107096-52-6 2-methyl-6-nitrobenzaldehyde 
• 77378-54-2 1-(bromomethyl)-6-methyl-2-nitrobenzene 
• 186267-75-4 5-methyl-1,4-dihydro-2H-benzo[d][1,3]oxazin-2-one 
• 146667-90-5 6-methyl-2-nitrostyrene 
• 393078-47-2 1-(2-methyl-6-nitrophenyl)-1,2-ethanediol 
• 393078-43-8 2,2-dimethyl-4-(2-methyl-6-nitrophenyl)-1,3-dioxolane 
• 107096-56-0 4-formyl-2,1-benzisoxazole 
• 145389-34-0 2-methyl-6-nitrobenzyl tosylate 
• 54915-42-3 2-Methyl-6-nitrobenzyl chloride 
• 65658-16-4 2-amino-6-methylbenzyl alcohol 
• 99646-81-8 2-amino-6-methylbenzaldehyde 

Relevant academic research and scientific papers

MOLECULES HAVING CERTAIN PESTICIDAL UTILITIES, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES RELATED THERETO

This disclosure relates to compounds having pesticidal utility against pests in phyla Nematoda, Arthropoda, and/or Mollusca, processes to produce such compounds and intermediates used in such processes, compositions containing such compounds, and processes of using such compounds against such pests. These compounds/molecules may be used, for example, as nematicides, acaricides, insecticides, miticides, and/or molluscicides. This document discloses compounds having the following formula (Formula One and/or Formula One-A).

Easy Access to Quinolin-2(1 H)-ones via a One-Pot Tandem Oxa-Michael-Aldol Sequence

An efficient strategy for the synthesis of a variety of quinolin-2(1 H)-one derivatives has been developed. The reaction proceeded from cinnamide derivatives via a tandem reaction in the presence of NaOH to afford the corresponding 2- quinolin-2(1 H)-one derivatives in good to excellent yields.

INHIBITORS OF CYTOSOLIC PHOSPHOLIPASE A2

This invention provides chemical inhibitors of the activity of various phospholipase enzymes, particularly cytosolic phospholipase A2 enzymes (cPLA2), more particularly including inhibitors of cytosolic phospholipase A2 alpha enzymes (cPLAα). In some embodiments, the inhibitors have the Formula I: wherein the constituent variables are as defined herein.

BICYCLIC DERIVATIVES AS PPAR MODULATORS

The present invention is directed to compounds represented by the following structural formula, Formula (I), and stereoisomers, pharmaceutically acceptable salts, solvates and hydrates thereof, wherein: (a) R2 is selected from the group consisting of C0-C8 alkyl and C1-4- heteroalkyl; (b) X is selected from the group consisting of a single bond, O, S, S(O)2 and N; (c) U is an aliphatic linker wherein one carbon atom of the aliphatic linker is optionally replaced with O, NH or S, and wherein such aliphatic linker is optionally substituted with from one to four substituents each independently selected from R30; (d) Y is selected from the group consisting of C, O, S, NH and a single bond; and (e) E is C(R3)(R4)A or A.

o-Nitroaryldioxolane for protection of pheromones. Study of the photodelivery of carbonylic compounds

o-Nitrophenyldioxolanes 1 to 12 have been prepared and the rate of their photocleavage determined Steric congestion in the molecule causes a decrease of the reaction rate. The decrease in the rate is especially important in the presence of a nitro group in a second phenyl ring.

Polyaza heterocycles. Part 3. Halogenation of 1-substituted quinoxalinocinnolines: mechanistic implications

Since it has been proposed that halogenation of quinoxalinocinnolines at C-10, using hydrogen chloride or bromide in chloroform, occurs through initial protonation of the substrate at N-12, attempts have been made to inhibit this protonation by the introduction of an additional substituent at C-1.Where this substituent is chloro, bromo or methyl, chlorination still occurs preferentially at C-10, although the yield and the reaction rate decrease along the series, lending weight to the mechanistic proposal.

Resist materials

A class of resist compositions sensitive to deep ultraviolet radiation includes a resin sensitive to acid and a composition that generates acid upon exposure to such radiation. A group of nitrobenzyl materials is particularly suitable for use as the acid generator.

Optionally substituted 1,2,3,5-tetrahydroimidezo(2,1-b)-quinazolin-2-ones and 6(H)-1,2,3,4-tetrahydropyimido(2,1-b)quinazolin-2-ones

Optionally substituted 1,2,3,5-tetrahydroimidazo[2,1-b]-quinazolin-2-ones and 6-[H]-1,2,3,4-tetrahydropyrimido[2,1-b]-quinazolin-2-ones or the pharmaceutically acceptable salts thereof are compounds useful as blood platelet anti-aggregative and/or antihypertensive and/or bronchodilator agents in mammals, including humans.